AQST vs NOC · rev $28.3M vs P/E 17, rev $20.76B
Aquestive Therapeutics Inc (AQST) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
AQST currently screens at market cap $493.0M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the AQST and NOC stock pages for the full models.
Not investment advice.